CreativeOne Wealth LLC Purchases 13,626 Shares of Option Care Health, Inc. $OPCH

Key Points

• CreativeOne Wealth LLC increased its position in Option Care Health, Inc. by 50.1%, now owning 40,849 shares worth approximately $1.43 million.
• Multiple institutional investors have significantly modified their holdings in Option Care Health, with Nuveen LLC acquiring a new stake valued at around $70.97 million.
• Option Care Health reported $1.42 billion in revenue for its last quarter, exceeding analysts' expectations, and set FY 2025 guidance of 1.650-1.720 EPS.

CreativeOne Wealth LLC grew its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 50.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 40,849 shares of the company's stock after buying an additional 13,626 shares during the period. CreativeOne Wealth LLC's holdings in Option Care Health were worth $1,428,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. Public Employees Retirement System of Ohio grew its position in shares of Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after buying an additional 332 shares during the last quarter. US Bancorp DE grew its holdings in shares of Option Care Health by 5.0% during the first quarter. US Bancorp DE now owns 8,199 shares of the company's stock valued at $287,000 after purchasing an additional 393 shares during the last quarter. State of Michigan Retirement System raised its position in shares of Option Care Health by 1.2% during the 1st quarter. State of Michigan Retirement System now owns 40,759 shares of the company's stock worth $1,425,000 after purchasing an additional 500 shares during the period. Louisiana State Employees Retirement System lifted its holdings in shares of Option Care Health by 1.1% in the 1st quarter. Louisiana State Employees Retirement System now owns 47,700 shares of the company's stock worth $1,667,000 after purchasing an additional 500 shares during the last quarter. Finally, State of Alaska Department of Revenue boosted its position in Option Care Health by 2.7% during the 1st quarter. State of Alaska Department of Revenue now owns 19,931 shares of the company's stock valued at $696,000 after purchasing an additional 525 shares during the period. 98.05% of the stock is currently owned by institutional investors.

Insider Activity at Option Care Health

In other Option Care Health news, Director Timothy P. Sullivan acquired 20,000 shares of Option Care Health stock in a transaction on Thursday, August 21st. The shares were purchased at an average cost of $27.51 per share, with a total value of $550,200.00. Following the completion of the purchase, the director owned 49,229 shares in the company, valued at $1,354,289.79. The trade was a 68.43% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of Option Care Health stock in a transaction on Wednesday, August 20th. The stock was acquired at an average cost of $27.15 per share, for a total transaction of $977,400.00. Following the completion of the purchase, the director owned 375,390 shares of the company's stock, valued at approximately $10,191,838.50. The trade was a 10.61% increase in their position. The disclosure for this purchase can be found here. Company insiders own 0.64% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on OPCH. Citigroup reiterated an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Barrington Research reissued an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research note on Thursday, July 10th. Finally, JMP Securities lifted their price target on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a report on Thursday, July 31st. Eight investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Stock Up 1.2%

NASDAQ:OPCH traded up $0.35 during trading hours on Wednesday, reaching $28.79. The company's stock had a trading volume of 1,036,152 shares, compared to its average volume of 1,855,932. The company has a market cap of $4.67 billion, a price-to-earnings ratio of 23.05, a price-to-earnings-growth ratio of 1.75 and a beta of 0.82. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The business's 50-day moving average is $29.47 and its 200-day moving average is $31.61. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The company had revenue of $1.42 billion during the quarter, compared to analysts' expectations of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The business's quarterly revenue was up 15.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Equities research analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.